000 02368cam  2200385zi 4500
0019.884461
003CaOODSP
00520231208122544
006m     o  d f      
007cr |n|||||||||
008200210t20202020onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-27/2020-2E-PDF|zH113-27/2020-2E
24500|aCyromazine and its associated end-use products : |bconsultation document.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2020.
264 4|c©2020
300 |a1 online resource (137 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed re-evaluation decision, |x1925-0967 ; |vPRVD2020-02
500 |aIssued also in French under title: Cyromazine et préparations commerciales connexes : document de consultation.
500 |aCover title.
500 |a"5 February 2020."
504 |aIncludes bibliographical references (pages 115-137).
520 |a"This document presents the proposed regulatory decision for the re-evaluation of cyromazine including the proposed risk mitigation measures to further protect human health and the environment, as well as the science evaluation on which the proposed decision was based. All products containing cyromazine registered in Canada are subject to this proposed re-evaluation decision. This document is subject to a 90-day public consultation period, during which the public including the pesticide manufacturers and stakeholders may submit written comments and additional information to the PMRA. The final re-evaluation decision will be published taking into consideration the comments and information received"--page 1.
650 0|aInsecticides|xCertification|zCanada.
650 0|aInsecticides|xToxicology.
650 0|aInsecticides|xEnvironmental aspects.
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tCyromazine et préparations commerciales connexes : |w(CaOODSP)9.884465
830#0|aProposed re-evaluation decision (Canada. Pest Management Regulatory Agency)|vPRVD2020-02.|w(CaOODSP)9.505201
85640|qPDF|s1.17 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/h113-27/H113-27-2020-2-eng.pdf|z(report)